SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-24-000057
Filing Date
2024-05-10
Accepted
2024-05-10 07:09:24
Documents
84
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20240331.htm   iXBRL 10-Q 1206325
2 EX-10.1 anip20240331-ex101.htm EX-10.1 259783
3 EX-31.1 anip-20240331x10qxexx311.htm EX-31.1 10310
4 EX-31.2 anip-20240331x10qxexx312.htm EX-31.2 9839
5 EX-32.1 anip-20240331x10qxexx321.htm EX-32.1 7021
  Complete submission text file 0001023024-24-000057.txt   8109463

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20240331.xsd EX-101.SCH 53538
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20240331_cal.xml EX-101.CAL 81062
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20240331_def.xml EX-101.DEF 342925
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20240331_lab.xml EX-101.LAB 742447
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20240331_pre.xml EX-101.PRE 548456
88 EXTRACTED XBRL INSTANCE DOCUMENT anip-20240331_htm.xml XML 1017920
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 24932862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)